GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Marizyme MRZM · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Marizyme

Our reporting

We have not reported on Marizyme yet.

Past results

Reported against what analysts expected

15 Nov 202417 Aug 20242 Jun 202423 Mar 202413 Nov 202318 Aug 2023
Earnings per share-0.01-0.03-0.05-0.19-0.58-0.48
Revenue——$32,855$150,562$181,535$184,739
Forecast$415,662$369,478$323,293—$230,923—

Key events

  1. 27 Jul 201829-to-1 reverse split
  2. 5 Apr 1995Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.